CVE-2021-1130 | Cisco DNA Center Cross-Site Scripting Vulnerability
A vulnerability in the web-based management interface of Cisco DNA Center software could allow an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack against a user of the interface of an affected device. The vulnerability exists because the web-based management interface does not properly validate user-supplied input. An attacker could exploit this vulnerability by persuading a user to click a crafted link. A successful exploit could allow the attacker to execute arbitrary script code in the context of the interface or access sensitive, browser-based information. To exploit this vulnerability, an attacker would need to have administrative credentials on the affected device.
Conclusion & alert: CVE-2021-1130 is rated Low Risk (38.1/100): CVSS Medium severity, with medium exploitation likelihood (EPSS 0.82%).Mandatory action: Monitor for updates and reassess as exploit intelligence or EPSS changes.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
Exploit prediction scoring system (EPSS) score for CVE-2021-1130
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).